Jump to ContentJump to Main Navigation
Contraceptive Risk – The FDA, Depo-Provera, and the Politics of Experimental Medicine - NYU Press Scholarship Online
Users without a subscription are not able to see the full content.

Contraceptive Risk: The FDA, Depo-Provera, and the Politics of Experimental Medicine

William Green


The odyssey of Depo-Provera is a study of the politics of contraceptive drug risk management, which involves a lengthy struggle over the scientific assessment of the drug's health risk and acceptability of the injectable drug's use. In this struggle, the FDA, the federal government's drug licensing agency, has limited authority to manage the drug's risk and is one participant in a fragmented system of drug risk management that includes The Upjohn Company, physicians, and state judges and legislators. Depo-Provera's odyssey joins its national controversy over its contraceptive approval to its s ... More

Keywords: medical malpractice, parole condition, probation condition, products liability, risk acceptability, risk assessment, risk management

Bibliographic Information

Print publication date: 2017 Print ISBN-13: 9781479876990
Published to NYU Press Scholarship Online: January 2018 DOI:10.18574/nyu/9781479876990.001.0001


Affiliations are at time of print publication.

William Green, author
Morehead State University